Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients

Journal of Oral Pathology and Medicine

Volumn 33, Issue 10, 2004, Pages 589-594

  Chen, C H ^a   Lin, Y S ^a   Lin, C C ^a   Yang, Y H ^a   Ho, Y P ^a   Tsai, C C ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Oncogene c erbB 2; Oral cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GENE PRODUCT; ONCOPROTEIN; PROTEIN P185;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BETEL NUT; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MASTICATION; METASTASIS; MOUTH CARCINOMA; ONCOGENE C ERB; ONCOGENE NEU; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; QUANTITATIVE ASSAY; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RECEPTOR, ERBB-2; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 7944231891     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00209.x     Document Type: Article

References (34)

1. Schechter AL, Stern DF, Vaidyanathan L, et al. The neu oncogene: an erb-B-related gene encoding a 185,000-M tumor antigen. Nature 1984; 312: 513-6.
2. Maguire HC, Greene MI. The neu (c-erbB-2) oncogene. Semin Oncol 1989; 16: 148-55.
3. King CR, Kraus MH, Aaronson SA. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 1985; 229: 974-6.
4. Kraus MH, Popescu NC, Amsbaugh SC, King CR. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 1987; 6: 605-10.
5. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 702-12.
6. Tandon AK, Clark GM, Charmness GC, Ullrich A, McGuire WL. Her-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 1989; 7: 1120-8.
7. Ro JS, El-Naggar A, Ro JY, Grignon DJ, Von Eschenbach AC, Ayala AG. C-erbB-2 amplification in node-negative human breast cancer. Cancer Res 1989; 49: 6941-4.
8. Clark GM, McGuire WL. Follow-up study of Her-2/neu amplification in primary breast cancer. Cancer Res 1991; 51: 944-8.
9. Iglehart JD, Kraus MH, Langton BL, Huper G, Kerns BJ, Marks JR. Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res 1990; 50: 6701-7.
10. Fontaine J, Tesseraux M, Klein V, Bastext G, Blin N. Gene amplification and expression of the neu (c-erbB-2) sequence in human mammary carcinoma. Oncology 1988; 45: 360-3.
11. Mori S, Mori Y, Mukaiyama T, Yamada Y, Sonobe Y, Matsushita H, et al. In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells. Jpn Cancer Res 1990; 81: 489-94.
12. Berchuck A, Kamel A, Whitaker R, et al. Overexpression of Her-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 1990; 50: 4087-91.
13. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC. Her-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol 1992; 47: 179-85.
14. Weiner DB, Nordberg J, Robinson R, et al. Expression of the neu gene-encoded protein (p185 neu) in human non-small cell carcinoma of the lung. Cancer Res 1990; 50: 421-5.
15. Yoshida K, Tsuda T, Matsumura T, et al. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1989; 57: 285-90.
16. Xia W, Lau YK, Zhang HZ, et al. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res 1997; 33: 3-9.
17. Xia W, Lau YK, Zhang HZ, et al. Combination of EGFR, Her-2/neu, and Her-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 1999; 5: 4164-74.
18. Alper O, Yamaguchi K, Hitomi J, et al. The presence of c-erbB-2 gene product related protein in culture medium conditioned by breast cancer cell line SK-BR-3. Cell Growth and Diff 1990; 1: 591-9.
19. Lin YJ, Clinton GM. A soluble protein related to the HER-2 proto-oncogene product is released from human breast carcinoma cells. Oncogene 1991; 6: 639-43.
20. Zabrecky JR, Lam T, McKenzie SJ, et al. The extra-cellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3. J Biol Chem 1991; 266: 1716-20.
21. Carney WP, Hamer PJ, Petit D, et al. Detection and quantitation of the human neu oncoprotein. J Tumor Marker Oncol 1991; 6: 53-72.
22. Leitzel K, Teramoto Y, Sampson E, Mauceri J, Langton BC, Demers L, et al. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients. J Clin Oncol 1992; 10: 1436-43.
23. Kynast B, Binder L, Max D, et al. Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patients. J Cancer Res Clin Oncol 1993; 119: 249-52.
24. Meden H, Max D, Fattahi-Meibodi A, et al. Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy. J Cancer Res Clin Oncol 1994; 120: 378-81.
25. Varley JM, Swallow JE, Brammer WJ, Whittaker JL, Walker R. Alterations to either c-erbB-2 (neu) or c-myc proto-oncogenes in breast carcinomas correlated with poor short-term prognosis. Oncogene 1987; 1: 423-30.
26. Salmon DJ, Clark GM, Wong SG, et al. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-82.
27. Khademi B, Shirazi FM, Vasei M, et al. The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors. Cancer Lett 2002; 223-30.
28. Nagler RM, Kerner H, Laufer D, Ben-Eliezer S, Minkov I, Ben-Itzhak O. Saquamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett 2002; 137-50.
29. Tsuji T, Saski K, Shinozaki F. An expression of squamous cell carcinoma-related antigen in oral cancers. Int J Oral Maxillofac Surg 1989; 18: 241-3.
30. Morioka H. Tumor-antigen (TA-4) of squamous cell carcinoma-its tissue distribution and its relationship to serum T-4 concentrations. Asia-Oceania J Obstet Gynecol 1980; 6: 91-7.
31. Godlenberg DM, Sharkey RM, Primus FJ. Carcinoembryonic antigen in histopathology. Immunoperoxidase staining of conventional tissue sections. J Natl Cancer Inst 1976; 57: 11-22.
32. Chang KM. Betel nut chewing and mouth cancer in Taiwan. J Formosa Med Assoc 1964; 63: 437-8.
33. Lu CT, Yen YY, Ho CS, et al. A case-control study of oral cancer in Changhua County, Taiwan. J Oral Pahol Med 1996; 25: 245-8.
34. Ko YC, Hung YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24: 450-3.